Skip to main content

Advertisement

Log in

Role of Alpha-2-Microglobulin in the Treatment of Osteoarthritic Knee Pain: a Brief Review of the Literature

  • Hot Topics in Pain and Headache (N. Rosen, Section Editor)
  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

A Correction to this article was published on 08 February 2020

This article has been updated

Abstract

Purpose of Review

Chronic knee pain remains a debilitating condition that remains difficult to manage. The purpose of this review, therefore, is to summarize current understanding of alpha-2-microglobulin in the treatment of osteoarthritic knee pain. Furthermore, we investigate its role in the anti-inflammatory properties of platelet-rich plasma (PRP).

Recent Findings

Alpha-2-microglobulin, a 720-kD protein complex, is an active protease inhibitor with tremendous anti-inflammatory properties in animal models. A growing body of evidence suggests that this complex is the most instrumental factor for cartilage preservation in PRP injections.

Summary

As an active component of platelet-rich plasma’s anti-inflammatory properties, alpha-2-microglobulin has been shown to be an active inhibitor of joint degeneration, cartilage preservation, and improvement in quality of life for patients with knee osteoarthritis compared with a multitude of other modalities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Change history

  • 08 February 2020

    The original publication listed author Alan Kaye as “A. Kaye,” but his name should read “A.D. Kaye.” The correct author name is presented in this article.

  • 08 February 2020

    The original publication listed author Alan Kaye as ���A. Kaye,��� but his name should read ���A.D. Kaye.��� The correct author name is presented in this article.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Holtedahl R. Atraumatic knee pain. Tidsskr Nor Legeforen. 2018;138(5). https://doi.org/10.4045/tidsskr.17.0594.

  2. Arthritis Basics. CDC. Retrieved from https://www.cdc.gov/arthritis/basics/index.html. 1 Jan 2019.

  3. Cisternas MG, Murphy L, Sacks JJ, Solomon DH, Pasta DJ, Helmick CG. Alternative methods for defining osteoarthritis and the impact on estimating prevalence in a US population-based survey. Arthritis Care Res. 2016;68(5):574–80.

    Article  Google Scholar 

  4. Ourradi K, Sharif M. Biomarkers for diagnosis of osteoartritis. JSM Bone Joint Dis. 2017;1(1):1002.

    Google Scholar 

  5. Hussain SM, Neilly DW, Baliga S, Patil S, Meek R. Knee osteoarthritis: a review of management options. Scott Med J. 2016;61(1):7–16. https://doi.org/10.1177/0036933015619588.

    Article  CAS  PubMed  Google Scholar 

  6. Sinusas K. Osteoarthritis: diagnosis and treatment. Am Fam Physician. 2012;85(1):49–56.

    PubMed  Google Scholar 

  7. Braun HJ, Gold GE. Diagnosis of osteoarthritis: imaging. Bone. 2011;51(2):278–88.

    Article  Google Scholar 

  8. Abhishek A, Doherty M. Diagnosis and clinical presentation of osteoarthritis. Rheum Dis Clin N Am. 2013;39(1):45–66. https://doi.org/10.1016/j.rdc.2012.10.007.

    Article  CAS  Google Scholar 

  9. Swagerty DL, Hellinger D. Radiographic assessment of osteoarthritis. Am Fam Physician. 2001;64(2):279–87.

    PubMed  Google Scholar 

  10. Culvenor AG, Øiestad BE, Hart HF, Stefanik JJ, Guermazi A, Crossley KM. Prevalence of knee osteoarthritis features on magnetic resonance imaging in asymptomatic uninjured adults: a systematic review and meta-analysis. Br J Sports Med. Published Online First: 09 June 2018. https://doi.org/10.1136/bjsports-2018-099257.

    Article  Google Scholar 

  11. Yucesoy B, Charles LE, Baker B, Burchfiel CM. Occupational and genetic risk factors for osteoarthritis: a review. Work. 2015;50(2):261–73.

    Article  Google Scholar 

  12. Glyn-Jones S, Palmser AJ, Agricola R, Price AJ, Vincent TL, Weinans H, et al. Osteoarthritis. Lancet. 2015;386(9991):376–87. https://doi.org/10.1016/S0140-6736(14)60802-3.

    Article  CAS  PubMed  Google Scholar 

  13. Murray CJ, Lopez AD. Evidence-based health policy—lessons from the global burden of disease study. Science. 1996;274(5288):740–3.

    Article  CAS  Google Scholar 

  14. Kulkarni K, Karssiens T, Kumar V, Pandit H. Obesity and osteoarthritis. Maturitas. 2016;89:22–8. https://doi.org/10.1016/j.maturitas.2016.04.006.

    Article  PubMed  Google Scholar 

  15. Kotlarz H, Gunnarsson CL, Fang H, Rizzo JA. Insurer and out-of-pocket costs of osteoarthritis in the US: evidence from national survey data. Arthritis Rheum. 2009;60(12):3546–53.

    Article  Google Scholar 

  16. Martel-Pelletier J, Barr AJ, Cicuttini FM, Conaghan PG, Cooper C, Goldring MB, et al. Osteoarthritis. Nat Rev Dis Primers. 2016;2:16072.

    Article  Google Scholar 

  17. Wan R, Hu J, Zhou Q, Wang J, Liu P, Wei Y. Application of co-expressed genes to articular cartilage: new hope for the treatment of osteoarthritis (review). Mol Med Rep. 2012;6(1):16–8. https://doi.org/10.3892/mmr.2012.859.

    Article  CAS  PubMed  Google Scholar 

  18. Luan Y, Kong L, Howell DR, Ilalov K, Fajardo M, Bai XH, et al. Inhibition of ADAMTS-7 and ADAMTS-12 degradation of cartilage oligomeric matrix protein by alpha-2-microglobulin. Osteoarthr Cartil. 2008;16(11):1413–20.

    Article  CAS  Google Scholar 

  19. Cuellar JM, Cuellar VG, Scuderi GJ. α2-microglobulin autologous protease inhibition technology. Phys Med Rehabil Clin N Am. 2016;27:909–18.

    Article  Google Scholar 

  20. Scuderi GJ, Golish SR, Cook FF, Cuellar JM, Bowser RP, Hanna LS. Identification of a novel fibronectin-aggrecan complex in the synovial fluid of knees with painful meniscal injury. J Bone Joint Surg Am. 2011 Feb 16;93(4):336–40. https://doi.org/10.2106/JBJS.J.00718.

    Article  PubMed  Google Scholar 

  21. Larsson S, Lohmander LS, Struglics A. Synovial fluid level of aggrecan ARGS fragments is a more sensitive marker of joint disease than glycosaminoglycan or aggrecan levels: a cross-sectional study. Arthritis Res Ther. 2009;11(3):R92.

    Article  Google Scholar 

  22. Maniar KH, Jones IA, Gopalakrishna R, Vangsness CT Jr. Lowering side effects of NSAID usage in osteoarthritis: recent attempts at minimizing dosage. Expert Opin Pharmacother. 2018;19(2):93–102. https://doi.org/10.1080/14656566.2017.1414802.

    Article  CAS  PubMed  Google Scholar 

  23. Law TY, Nguyen C, Frank RM, Rosas S, McCormick F. Current concepts on the use of corticosteroid injections for knee osteoarthritis. Phys Sportsmed. 2015;43(3):269–73. https://doi.org/10.1080/00913847.2015.1017440.

    Article  PubMed  Google Scholar 

  24. Gregori D, Giacovelli G, Minto C, Barbetta B, Gualtieri F, Azzolina D, et al. Association of pharmacological treatments with long-term pain control in patients with knee osteoarthritis: a systematic review and meta-analysis. JAMA. 2018;320(24):2564–79. https://doi.org/10.1001/jama.2018.19319.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Bliddal H, Leeds AR, Christensen R. Osteoarthritis, obesity and weight loss: evidence, hypotheses and horizons - a scoping review. Obes Rev. 2014;15(7):578–86.

    Article  CAS  Google Scholar 

  26. Rizzo J. Patients’ mental models and adherence to outpatient physical therapy home exercise programs. Physiother Theory Pract. 2015;31(4):253–9. https://doi.org/10.3109/09593985.2014.1003117.

    Article  PubMed  Google Scholar 

  27. Hackinger S, Trajanoska K, Styrkarsdottir U, Zengini E, Steinberg J, Ritchie G, et al. Evaluation of shared genetic aetiology between osteoarthritis and bone mineral density identifies SMAD3 as a novel osteoarthritis risk locus. Hum Mol Genet. 2017;26(19):3850–8.

    Article  CAS  Google Scholar 

  28. Evidence Development and Standards Branch. Health Quality Ontario. Arthroscopic debridement of the knee: an evidence update. Ont Health Technol Assess Ser. 2014;14(13):1–43 Published 2014 Nov 1.

    Google Scholar 

  29. van der Woude J, Wiegant K, van Heerwaarden RJ, Spruijt S, van Roermund PM, Custers R, et al. Knee joint distraction compared with high tibial osteotomy: a randomized controlled trial. Knee Surg Sports Traumatol Arthrosc. 2016;25(3):876–86.

    Article  Google Scholar 

  30. Intema F, Van Roermund PM, Marijnissen AC, Cotofana S, Eckstein F, Castelein RM, et al. Tissue structure modification in knee osteoarthritis by use of joint distraction: an open 1-year pilot study. Ann Rheum Dis. 2011;70(8):1441–6.

    Article  Google Scholar 

  31. Wang S, Wei X, Zhou J, Zhang J, Li K, Chen Q, et al. Identification of alpha 2 microglobulin (A2M) as a master inhibitor of cartilage degrading factors that attenuates post-traumatic osteoarthritis progression. Arthritis Rheum. 2014;66(7):1843–53. https://doi.org/10.1002/art.38576.

    Article  CAS  Google Scholar 

  32. Doan N, Gettins PG. Human alpha2-macroglobulin is composed of multiple domains, as predicted by homology with complement component C3. Biochem J. 2007;407(1):23–30.

    Article  CAS  Google Scholar 

  33. Sottrup-Jensen L, Stepanik TM, Kristensen T, Wjerzbicki DM, Jones CM, Lenblad PB, et al. Primary structure of human alpha 2-macroglobulin. V. The complete structure. J Biol Chem. 1984;259(13):8318–27.

    CAS  PubMed  Google Scholar 

  34. Zhang Y, Wei X, Browning S, Scuderi G, Hanna LS, Wei L. Targeted designed variants of alpha-2-macroglobulin (A2M) attenuate cartilage degeneration in a rat model of osteoarthritis induced by anterior cruciate ligament transection. Arthritis Res Ther. 2017;19(175). https://doi.org/10.1186/s13075-017-1363-4.

  35. Wang S, Wei X, Zhou J, Zhang J, Li K, Chen Q, Terek R, Fleming BC, Goldring MB, Ehrlich MG, Zhang G, … Wei L Identification of Α2-macroglobulin as a master inhibitor of cartilage-degrading factors that attenuates the progression of posttraumatic osteoarthritis. Arthritis Rheumatol. 2014;66(1843)1853. https://doi.org/10.1002/art.38576.

    Article  CAS  Google Scholar 

  36. Cuellar JM, Browning SR, Cuellar VG, Golish SR, Hanna L, Scuderi G. Poster 10 is there a chondroprotective effect of autologous platelet integrated concentrate (APIC) on an osteoarthritis (OA) rabbit model? A pilot study. Pm&R. 2012. https://doi.org/10.1016/j.pmrj.2012.09.640.

    Article  Google Scholar 

  37. Tortorella MD, Arner EC, Hills R, Easton A, Korte-Sarfaty J, Fok K, et al. Α2-macroglobulin is a novel substrate for ADAMTS-4 and ADAMTS-5 and represents an endogenous inhibitor of these enzymes. J Biol Chem. 2004;279:17554–61. https://doi.org/10.1074/jbc.M313041200.

    Article  CAS  PubMed  Google Scholar 

  38. Cole BJ, Karas V, Hussey K, Pilz K, Fortier LA. Hyaluronic acid versus platelet-rich plasma: a prospective, double-blind randomized controlled trial comparing clinical outcomes and effects on intra-articular biology for the treatment of knee osteoarthritis. Am J Sports Med. 2017;45:339–46. https://doi.org/10.1177/0363546516665809.

    Article  PubMed  Google Scholar 

  39. Paterson KL, Nicholls M, Bennell KL, Bates D. Intra-articular injection of photo-activated platelet-rich plasma in patients with knee osteoarthritis: a double-blind, randomized controlled pilot study. BMC Musculoskelet Disord. 2016;17:67. https://doi.org/10.1186/s12891-016-0920-3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Duif C, Vogel T, Topcuoglu F, Spyrou G, von Schulze Pellengahr C, Lahner M. Does intraoperative application of leukocyte-poor platelet-rich plasma during arthroscopy for knee degeneration affect postoperative pain, function and quality of life? A 12-month randomized controlled double-blind trial. Arch Orthop Trauma Surg. 2015;135:971–7. https://doi.org/10.1007/s00402-015-2227-5.

    Article  PubMed  Google Scholar 

  41. Spaková T, Rosocha J, Lacko M, Harvanová D, Gharaibeh A. Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid. Am J Phys Med Rehabil. 2012;91:411–7. https://doi.org/10.1097/PHM.0b013e3182aab72.

    Article  PubMed  Google Scholar 

  42. Kon E, Buda R, Filardo G, Di Martino A, Timoncini A, Cenacchi A, et al. Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: from early degeneration to osteoarthritis. Arthroscopy. 2011;27:1490–501. https://doi.org/10.1016/j.arthro.2011.05.011.

    Article  PubMed  Google Scholar 

  43. Charousset C, Zaoui A, Bellaiche L, Bouyer B. Are multiple platelet-rich plasma injections useful for treatment of chronic patellar tendinopathy in athletes?: a prospective study. Am J Sports Med. 2014;42:906–11. https://doi.org/10.1177/0363546513519964.

    Article  PubMed  Google Scholar 

  44. Li M, Zhang C, Ai Z, Yuan T, Feng Y, Jia W. Therapeutic effectiveness of intra-knee-articular injection of platelet-rich plasma on knee articular cartilage degeneration. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2011.

  45. Chen SH, Kuan TS, Kao MJ, Wu WT, Chou LW. Clinical effectiveness in severe knee osteoarthritis after intra-articular platelet-rich plasma therapy in association with hyaluronic acid injection: three case reports. Clin Interv Aging. 2016;Volume 11:1213–9. https://doi.org/10.2147/CIA.S114795.

    Article  Google Scholar 

  46. Gobbi A, Karnatzikos G, Mahajan V, Malchira S. Platelet-rich plasma treatment in symptomatic patients with knee osteoarthritis: preliminary results in a group of active patients. Sports Health. 2012;4:162–72. https://doi.org/10.1177/1941738111431801.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Gibbs N, Diamond R, Sekyere EO, Thomas WD. Management of knee osteoarthritis by combined stromal vascular fraction cell therapy, platelet-rich plasma, and musculoskeletal exercises: a case series. J Pain Res. 2015. https://doi.org/10.2147/JPR.S92090.

  48. Bowman KF, Muller B, Middleton K, Fink C, Harner CD, Fu FH. Progression of patellar tendinitis following treatment with platelet-rich plasma: case reports. Knee Surg Sports Traumatol Arthrosc. 2013;21:2035–9. https://doi.org/10.1007/s00167-013-2549-1.

    Article  PubMed  Google Scholar 

  49. ClinicalTrials.gov. New York (NY): New York University School of Medicine 2017 Nov 1–2019 Mar 12. Identifier NCT03656575, Reduction of pro-inflammatory synovial fluid biomarkers in osteoarthritis of the knee with alpha-2 macroglobulin; https://clinicaltrials.gov/ct2/show/NCT03656575?cond=Reduction+of+Pro-Inflammatory+Synovial+Fluid+Biomarkers+in+Osteoarthritis+of+the+Knee+With+Alpha-2+Macroglobulin&rank=1.

  50. Scuderi GJ. ClinicalTrials.gov. Palo Alto (CA): Stanford University Hospital 2017 Oct 9. Identifier NCT01613833, Serum and synovium protease inhibitor levels in primary and secondary osteoarthritic joints; https://clinicaltrials.gov/ct2/show/NCT01613833

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vwaire Orhurhu.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Hot Topics in Pain and Headache

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Orhurhu, V., Schwartz, R., Potts, J. et al. Role of Alpha-2-Microglobulin in the Treatment of Osteoarthritic Knee Pain: a Brief Review of the Literature. Curr Pain Headache Rep 23, 82 (2019). https://doi.org/10.1007/s11916-019-0822-9

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11916-019-0822-9

Keywords

Navigation